Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA138519 ID: 138519

EGFR inhibition prevents liver cirrhosis and hepatocellular carcinoma

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
AccessionPRJNA138519; GEO: GSE27641
TypeUmbrella project
PublicationsFuchs BC et al., "Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.", Hepatology, 2014 Apr;59(4):1577-90
SubmissionRegistration date: 2-Mar-2011
University of Texas Southwestern Medical Center
RelevanceSuperseries
Project Data:
Resource NameNumber
of Links
Publications
PubMed1
PMC1
Other datasets
GEO DataSets4
GEO Data Details
ParameterValue
Data volume, Spots813697
Data volume, Processed Mbytes21
Data volume, Supplementary Mbytes4
EGFR inhibition prevents liver cirrhosis and hepatocellular carcinoma encompasses the following 3 sub-projects:
Project TypeNumber of Projects
Transcriptome or Gene expression3
BioProject
accession
OrganismTitle
PRJNA141763Mus musculusGene expression profile of liver tissue in carbon tetrachloride (CCl4)-treated mouse treated with erlotinib (University of Texas Southwestern...)
PRJNA141685Rattus norvegicusGene expression profile of liver tissue in low-dose, repeated diethylnitrosamine (DEN)-treated rat treated with erlotinib (Icahn School of Medicine...)
PRJNA141761Rattus norvegicusGene expression profile of hepatocellular carcinoma in low-dose, repeated diethylnitrosamine (DEN)-treated rat treated with erlotinib (Icahn School of Medicine...)

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center